Exact Therapeutics AS Stock

Exact Therapeutics AS P/B

The P/B (Price-to-Book Ratio) of Exact Therapeutics AS (EXTX.OL) as of Aug 15, 2026 is 4.02. In the previous year, P/B (Price-to-Book Ratio) was 1.07 — a change of 276.28% (higher).

P/B

4.02

YoY

276.28%

Last updated:

P/B (Price-to-Book Ratio) of Exact Therapeutics AS is 2026 4.02 . P/B (Price-to-Book Ratio) of Exact Therapeutics AS was 2025 1.07 . It decreases by 276.28% higher compared to the previous year.
Access this data via the Eulerpool API

Exact Therapeutics AS Stock analysis

What does Exact Therapeutics AS do? Exact Therapeutics AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Exact Therapeutics AS stock

P/B (Price-to-Book Ratio) of Exact Therapeutics AS is 4.02 in 2026.

P/B (Price-to-Book Ratio) of Exact Therapeutics AS changed from 1.07 to 4.02, representing a 276.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Exact Therapeutics AS since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Exact Therapeutics AS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Exact Therapeutics AS

All Key Metrics — Exact Therapeutics AS